Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -151,091 | -80,100 | -311,458 | -239,439 | -131,730 |
| Depreciation Amortization | -3,236 | -1,798 | -1,319 | 676 | 1,195 |
| Accounts receivable | -8,749 | -4,311 | -8,458 | -2,431 | 0 |
| Accounts payable and accrued liabilities | 8,319 | 3,376 | 1,565 | 1,383 | 1,166 |
| Other Working Capital | -14,732 | -9,006 | -10,175 | -2,762 | -3,995 |
| Other Operating Activity | 22,660 | 11,495 | 72,130 | 55,923 | 14,409 |
| Operating Cash Flow | $-146,829 | $-80,344 | $-257,715 | $-186,650 | $-118,955 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 197,227 | 107,833 | -63,916 | -106,240 | 68,066 |
| PPE Investments | -358 | -82 | -15,783 | -15,660 | -204 |
| Purchase Sale Intangibles | N/A | N/A | -7,500 | -7,500 | N/A |
| Other Investing Activity | 0 | 0 | -7,500 | -7,500 | 0 |
| Investing Cash Flow | $196,869 | $107,751 | $-87,199 | $-129,400 | $67,862 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 125,000 | 125,000 | N/A |
| Common Stock Issued | 1,167 | 100 | 164,530 | 178,023 | 15,847 |
| Other Financing Activity | 0 | 0 | 12,268 | -2,187 | 0 |
| Financing Cash Flow | $1,167 | $100 | $301,798 | $300,836 | $15,847 |
| Exchange Rate Effect | -43 | -52 | N/A | 0 | 0 |
| Beginning Cash Position | 54,875 | 54,875 | 97,991 | 97,991 | 97,991 |
| End Cash Position | 106,039 | 82,330 | 54,875 | 82,777 | 62,745 |
| Net Cash Flow | $51,164 | $27,455 | $-43,116 | $-15,214 | $-35,246 |
| Free Cash Flow | |||||
| Operating Cash Flow | -146,829 | -80,344 | -257,715 | -186,650 | -118,955 |
| Capital Expenditure | -358 | -82 | -15,783 | -15,660 | -204 |
| Free Cash Flow | -147,187 | -80,426 | -273,498 | -202,310 | -119,159 |